Translational Research in Serious Human Diseases

0536559 - ÚŽFG 2021 RIV CZ eng M - Část monografie knihy
Nguyen, The Duong - Ellederová, Zdeňka - Motlík, Jan
Reprogramming - a promise of regenerative medicine.
Translational Research in Serious Human Diseases. Praha: Academia, 2020 - (Kello, M.; Strnadel, J.; Klempir, J.; Roth, J.; Myslivcová-Fučíková, A.; Hansíková, H.; Kozák, I.), s. 141-147. ISBN 978-80-200-3158-7
Grant CEP: GA MŠMT(CZ) LO1609
Institucionální podpora: RVO:67985904
Klíčová slova: regenerative medicine * in vivo reprograming * transcription factors
Obor OECD: Cell biology

Reprogramming cells into induced pluripotent stem cells (iPSc) is a part of regenerative medicine that can provide specific cell types to replace lost or damaged tissue in degenerative diseases or injury. In this review, we provide a new strategies and advances of in vivo reprogramming in case of four disease model and also discuss the future challenges of these preclinical studies for the clinical settings.
Trvalý link: http://hdl.handle.net/11104/0314326